PatSnap Weekly: 2017 March Week 5
Welcome to the final PatSnap Weekly of March. This week, a shadowing hand, a potential cure for type 2 diabetes and the largest artificial sun ever created.
Elon Musk founds AI company
SpaceX CEO begins new venture to develop brain-technology interfaces. The technology, being developed by Neuralink could radically change the way people interact with computers as well as offer treatments for debilitating diseases.
Largest artificial sun turned on
German Aerospace Centre (DLR) activate largest ‘artificial sun’. The project, known as Synlight, consists of 149 high power spotlights capable of producing 3,000 degrees C. The technology is hoped to increase innovation in the production of solar cells.
Robot hand demonstratedLondon robotics firm Shadow Robot demonstrates robotic hand which follows the hand movements of human operator. The technology could lead to new options in robotic surgery and manufacturing.
Singaporean AI defeats trafficAI routing algorithm developed by team at the Nanyang Technological University in Singapore capable of preventing snap traffic jams.
3D printed cartilage grown in mice
Research team in Sweden use stem cells to successfully implant 3D printed human cartilage into baby mice. Technique could lead to radical new treatments for growing new body parts in humans.
MS drug receives FDA approval
US Food and Drug Administration grants first ever drug for primary progressive MS. Ocrelizumab, branded as Ocrevus, also approved for treatment of more common relapsing-remitting form of disease.
Cure for type-2 diabetes
Team from University of California, San Diego manage to completely reverse effects of diabetes in mice using daily dose of new drug.
Apple wins Chinese IP battle
Chinese court overturn 2016 ruling claiming Apple violated the intellectual property of short lived tech startup Shenzhen Baili. The firm, which media companies struggled to track down at the time of the case, contended the iPhone 6 violated certain elements of their 100C model phone.
Universities receive CRISPR patent
European Patent Office (EPO) grants Universities of California and Vienna patent to use revolutionary gene editing technology CRISPR. The rights to use and further develop the technique have been mired in legal disputes almost since discovery.